Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005994 | Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy | completed | N/A | — | University of RochesterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00007917 | Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| Effects of OM-174 in Adult Patients With Solid Tumors(OM-174) |
| completed |
| Phase 1 |
| 27 |
| Centre Hospitalier Universitaire DijonOTHER |
| 0 |
| Feb 28, 2013 |
| clinicaltrials |
| NCT00003884 | Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone | completed | Phase 3 | 600 | NovartisINDUSTRY | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00005811 | Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 77 | National Cancer Institute (NCI)NIH | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00529022 | Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | completed | Phase 1 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00002980 | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer | completed | Phase 1 | — | California Cancer ConsortiumNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00544284 | Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00500422 | Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | completed | Phase 1 | 134 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00791063 | 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT | completed | Phase 2 | 10 | Aposense Ltd.INDUSTRY | 0 | Feb 13, 2013 | clinicaltrials |
| NCT00428545 | Bevacizumab and Bortezomib in Patients With Advanced Malignancy | completed | Phase 1 | 104 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00955812 | STAT3 Inhibitor for Solid Tumors | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00002862 | Perillyl Alcohol in Treating Patients With Refractory Cancer | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00002946 | Penclomedine in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003330 | Interleukin-12 in Treating Patients With Advanced Cancer | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004229 | Endostatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00006221 | BMS-247550 in Treating Patients With Advanced Cancers | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003191 | Fenretinide in Treating Children With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2013 | clinicaltrials |
| NCT00003249 | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00287937 | Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01602627 | Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies | terminated | Phase 1 | 2 | Dale Shepard, MD, PhDOTHER | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00002759 | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00002909 | Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00003288 | Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00003370 | Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 3 | Feb 5, 2013 | clinicaltrials |
| NCT00005577 | Gemcitabine in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00006102 | Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 7 | Feb 5, 2013 | clinicaltrials |
| NCT00316953 | Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00611689 | Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors | completed | Phase 1 | 45 | SCRI Development Innovations, LLCOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00003451 | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00004079 | Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00005604 | Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006242 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00066625 | Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00068484 | A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00006000 | SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00238225 | Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00275093 | Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function | completed | Phase 1 | 130 | National Cancer Institute (NCI)NIH | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00244868 | Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer | completed | Phase 3 | 720 | Fox Chase Cancer CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00898027 | Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer | terminated | — | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Jan 29, 2013 | clinicaltrials |
| NCT01358019 | A Study of LY2523355 in Patients With Solid Cancer(2523355-001) | completed | Phase 1 | 18 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00010205 | Benzoylphenylurea in Treating Patients With Advanced Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Mar 5, 2013source: clinicaltrials